Complete Response of a Patient With Metastatic Sarcomatoid Renal Cell Carcinoma to a Programmed Death-1 Checkpoint Inhibitor

被引：5

作者：

El Mouallem, Nemer ^{[1
]}

Smith, Steven C. ^{[1
]}

Paul, Asit K. ^{[1
]}

机构：

[1] Virginia Commonwealth Univ, Richmond, VA USA

来源：

JOURNAL OF ONCOLOGY PRACTICE | 2018年 / 14卷 / 08期

关键词：

D O I：

10.1200/JOP.18.00213

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：511 / +

页数：4

共 5 条

[1] Sarcomatoid renal cell carcinoma: Biology and treatment advances [J].

El Mouallem, Nemer ;

Smith, Steven C. ;

Paul, Asit K. .

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (06) :265-271

[2] PD-1 and PD-L1 Expression in Renal Cell Carcinoma with Sarcomatoid Differentiation [J].

Joseph, Richard W. ;

Millis, Sherri Z. ;

Carballido, Estrella M. ;

Bryant, David ;

Gatalica, Zoran ;

Reddy, Sandeep ;

Bryce, Alan H. ;

Vogelzang, Nicholas J. ;

Stanton, Melissa L. ;

Castle, Erik P. ;

Ho, Thai H. .

CANCER IMMUNOLOGY RESEARCH, 2015, 3 (12) :1303-1307

[3]

Keskin SK, 2017, J UROLOGY, V198, P530, DOI 10.1016/j.juro.2017.04.067

[4] The Place of FDG PET/CT in Renal Cell Carcinoma: Value and Limitations [J].

Liu, Yiyan .

FRONTIERS IN ONCOLOGY, 2016, 6

[5] Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma [J].

Motzer, R. J. ;

Escudier, B. ;

McDermott, D. F. ;

George, S. ;

Hammers, H. J. ;

Srinivas, S. ;

Tykodi, S. S. ;

Sosman, J. A. ;

Procopio, G. ;

Plimack, E. R. ;

Castellano, D. ;

Choueiri, T. K. ;

Gurney, H. ;

Donskov, F. ;

Bono, P. ;

Wagstaff, J. ;

Gauler, T. C. ;

Ueda, T. ;

Tomita, Y. ;

Schutz, F. A. ;

Kollmannsberger, C. ;

Larkin, J. ;

Ravaud, A. ;

Simon, J. S. ;

Xu, L-A ;

Waxman, I. M. ;

Sharma, P. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (19) :1803-1813

← 1 →